Behenic Acid

Behenic Acid

SCHEMBL5873243

CC(=O)c1ccc2ccccc2c1.CCCCCCCCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.55
NPC1 O15118 1/20 0.55
LMNA P02545 1/20 0.55
RAB9A P51151 1/20 0.55
CCKBR P32239 1/20 0.53
HPGD P15428 2/20 0.50
HDAC3 O15379 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
KDM4E B2RXH2 1/20 0.50
EPHX1 P07099 1/20 0.50
CYP1A2 P05177 1/20 0.50
PPARG P37231 7/20 0.49
PPARA Q07869 7/20 0.49
NR1H4 Q96RI1 1/20 0.49
ALDH1A1 P00352 3/20 0.49
MAPT P10636 1/20 0.49
PPARD Q03181 6/20 0.49
HDAC11 Q96DB2 5/20 0.49
TSHR P16473 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Nonanone SCHEMBL28249498 0.90 SMN1; SMN2 (0.59) SMN1; SMN2NPC1LMNARAB9AHPGD
Stearic Acid SCHEMBL27500805 0.85 GPR84 (0.63) PPARGPPARAALDH1A1MAPTPPARD
Decanoic Acid SCHEMBL31619443 0.84 GPR84 (0.68) LMNACYP1A2PPARGPPARAALDH1A1
Stearic Acid SCHEMBL16632630 0.84 GPR84 (0.68) LMNACYP1A2PPARGPPARAALDH1A1
Myristic Acid SCHEMBL29097493 0.84 GPR84 (0.68) LMNACYP1A2PPARGPPARAALDH1A1
Stearic Acid SCHEMBL29123159 0.84 GPR84 (0.68) LMNACYP1A2PPARGPPARAALDH1A1
Octanoic Acid SCHEMBL27939700 0.84 GPR84 (0.68) LMNACYP1A2PPARGPPARAALDH1A1
Myristic Acid SCHEMBL2124139 0.83 CES2 (0.62) HDAC3HDAC1HDAC2PPARGPPARA
Stearic Acid SCHEMBL27740225 0.83 CES2 (0.62) HDAC3HDAC1HDAC2PPARGPPARA
Anthracene SCHEMBL9561628 0.83 AKR1B1 (0.61) SMN1; SMN2NPC1LMNARAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103365133-B Production process for colorant, colorant composition, toner, ink for ink jet recording and color filter KONICA MINOLTA BUSINESS TECH 2015-06-17 CN disclosed
CN-103365133-A Production process for colorant, colorant composition, toner, ink for ink jet recording and color filter KONICA MINOLTA BUSINESS TECH 2013-10-23 CN disclosed
US-7025816-B2 Anthraquinone dye and inkjet recording liquid KONICA MINOLTA HOLDINGS, INC. (JP) 2006-04-11 US disclosed
US-20050103226-A1 Anthraquinone dye and inkjet recording liquid KONICA MINOLTA HOLDINGS, INC. (JP) 2005-05-19 US disclosed
US-5892033-A THERMAL TRANSFER RECORDING; ELECTROSTATIC IMAGING KONICA CORPORATION (JP) 1999-04-06 US disclosed
EP-0763569-A1 metal complex methin dye KONICA CORPORATION (JP) 1997-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050103226-A1 Anthraquinone dye and inkjet recording liquid MLLT3, GNPAT, IK SMN1; SMN2 4059/4885NPC1 4375/4885LMNA 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.